跳至主要内容
临床试验/NCT05236751
NCT05236751已完成不适用

Impact of Severe Intraoperative Hyperglycemia on Infection Rate After Elective Intracranial Interventions

Boston Medical Center3 个研究点 分布在 3 个国家目标入组 52 人开始时间: 2021年5月24日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
52
试验地点
3
主要终点
Postoperative infection

研究概览

简要总结

Poor glycemic control is recognized as a risk factor for postoperative infection. For the neurosurgical patient, postoperative infection can lead to devastating complications such as meningitis, encephalitis and death. Neurosurgical patients often receive high doses of medications that increase blood glucose levels such as steroids, placing them at a potentially higher risk for postoperative infection. The purpose of this multisite observational study is to assess the impact of severe intraoperative hyperglycemia as a risk factor for postoperative infection in the neurosurgical patient.

详细描述

This is a multisite [3 locations] prospective observational study of adult patients (18-89 years old) scheduled for elective intracranial (open or endoscopic) procedures that require general anesthesia and a hospital stay of at least 1 day after the surgery. All sites will follow the standard of care clinical protocol for glycemic management that was developed at Boston Medical Center (BMC). Laboratory tests will be collected at the discretion of the primary clinician. This observational study does not require any change to routine clinical practice.

The following perioperative data (timeframe between Pre-Procedure Clinic visit through Post-Anesthesia Care Unit discharge): blood glucose measurements, total insulin dose, total dexamethasone dose, estimated intraoperative blood loss, antibiotic prophylaxis regimen.

The patient's electronic medical records data will be reviewed 7 days after the neurosurgical procedure to abstract all available culture data (blood, urine, sputum, CSF), available treatment regimen data prescribed for infection (antibiotics), complications from hyperglycemia (diabetic ketoacidosis, hyperglycemic nonketotic coma) or insulin therapy (hypoglycemia episodes). Intensive care unit (ICU) and hospital length of stay will also be obtained form the medical records.

The investigators anticipate finding four groups of patients with regards to intraoperative blood glucose levels and management: 1) patients with no episodes of severe intraoperative hyperglycemia, 2) patients with intraoperative hyperglycemia who received insulin treatment, 3) patients with intraoperative hyperglycemia who did not receive insulin treatment and 4) patients with no available laboratory data.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 89 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients scheduled for elective intracranial (open surgical or endoscopic) intervention
  • General anesthesia
  • Hospital stay of at least 1 day post-procedure

排除标准

  • Diagnosis of infection (local or systemic) in preoperative period
  • Emergency procedures

结局指标

主要结局

Postoperative infection

时间窗: 7 days after surgery

Proportion of patients diagnosed with infection (such as wound, pulmonary, urological, blood) in the postoperative period

次要结局

  • Intraoperative glucose level in whole blood(before incision and at the end of surgery)
  • Intraoperative dose of insulin(During surgical procedure)
  • Perioperative complications(preoperative clinic visit to within 7 days of surgery)
  • Duration of stay in ICU in hours(30 days)
  • Antibiotic prophylaxis scheme(Preoperatively)
  • Dosages and regimen of dexamethasone in the perioperative period(preoperative clinic visit to within 7 days of surgery)
  • Duration of stay in hospital in days(30 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验